Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Trident Lifeline Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543616 | NSE: Not Listed

Watchlist

NSE BSE

275

19-Dec-2024

Open
High
Low
Previous Close

273.65
278
273.65
280.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1800
495990
339.00
136.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

316.23
44.90
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

332.49
N/A
5.35

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
27.03

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
24.91

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
17.08

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 15.66 9.93 57.70% 14.74 8.64 70.60% 0.00 8.46 -100.00% 0.00 9.41 -100.00%
Expenses 11.24 7.74 45.22% 10.66 6.88 54.94% 0.00 6.51 -100.00% 0.00 7.43 -100.00%
EBITDA 4.42 2.19 101.83% 4.08 1.76 131.82% 0.00 1.95 -100.00% 0.00 1.98 -100.00%
EBIDTM 28.24% 22.07% 27.67% 20.40% 0.00% 23.07% 0.00% 21.03%
Other Income 0.52 0.38 36.84% 0.47 0.33 42.42% 0.00 0.63 -100.00% 0.00 0.39 -100.00%
Interest 0.27 0.11 145.45% 0.20 0.10 100.00% 0.00 0.15 -100.00% 0.00 0.13 -100.00%
Depreciation 0.16 0.16 0.00% 0.33 0.13 153.85% 0.00 0.12 -100.00% 0.00 0.13 -100.00%
PBT 4.52 2.31 95.67% 4.02 1.86 116.13% 0.00 2.31 -100.00% 0.00 2.12 -100.00%
Tax 1.13 0.60 88.33% 1.01 0.46 119.57% 0.00 0.34 -100.00% 0.00 0.10 -100.00%
PAT 3.39 1.71 98.25% 3.01 1.40 115.00% 0.00 1.98 -100.00% 0.00 2.01 -100.00%
PATM 21.65% 17.18% 20.45% 16.22% 0.00% 23.35% 0.00% 21.42%
EPS 2.95 1.48 99.32% 2.62 1.22 114.75% 0.00 1.72 -100.00% 0.00 1.75 -100.00%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 15.45 4.60 235.87% 13.15 8.64 52.20% 0.00 8.46 -100.00% 0.00 9.41 -100.00%
Expenses 11.40 4.55 150.55% 10.66 6.88 54.94% 0.00 6.51 -100.00% 0.00 7.43 -100.00%
EBITDA 4.05 0.05 8,000.00% 2.50 1.76 42.05% 0.00 1.95 -100.00% 0.00 1.98 -100.00%
EBIDTM 26.23% 1.09% 18.99% 20.40% 0.00% 23.06% 0.00% 21.03%
Other Income 0.54 0.38 42.11% 1.15 0.33 248.48% 0.00 0.64 -100.00% 0.00 0.39 -100.00%
Interest 0.50 0.09 455.56% 0.49 0.10 390.00% 0.00 0.15 -100.00% 0.00 0.13 -100.00%
Depreciation 0.16 0.06 166.67% 0.54 0.13 315.38% 0.00 0.12 -100.00% 0.00 0.13 -100.00%
PBT 3.93 0.28 1,303.57% 2.61 1.86 40.32% 0.00 2.31 -100.00% 0.00 2.12 -100.00%
Tax 1.13 -0.34 - 1.01 0.46 119.57% 0.00 0.34 -100.00% 0.00 0.10 -100.00%
PAT 2.81 0.62 353.23% 1.60 1.40 14.29% 0.00 1.98 -100.00% 0.00 2.01 -100.00%
PATM 18.18% 13.45% 12.17% 16.22% 0.00% 23.37% 0.00% 21.41%
EPS 2.69 0.54 398.15% 1.99 1.22 63.11% 0.00 1.72 -100.00% 0.00 1.75 -100.00%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales - 44.65 31.69 21.77 9.62 Net Sales Growth - 40.90% 45.57% 126.30% Cost Of Goods Sold - 25.11 16.41 10.77 5.51 Gross Profit - 19.54 15.29 11.00 4.11 GP Margin - 43.76% 48.25% 50.53% 42.72% Total Expenditure - 35.78 25.43 19.06 8.37 Power & Fuel Cost - 0.07 0.03 0.02 0.02 % Of Sales - 0.16% 0.09% 0.09% 0.21% Employee Cost - 1.55 1.39 1.10 0.70 % Of Sales - 3.47% 4.39% 5.05% 7.28% Manufacturing Exp. - 5.92 4.64 4.63 1.29 % Of Sales - 13.26% 14.64% 21.27% 13.41% General & Admin Exp. - 1.00 0.79 0.81 0.38 % Of Sales - 2.24% 2.49% 3.72% 3.95% Selling & Distn. Exp. - 1.43 1.75 1.62 0.45 % Of Sales - 3.20% 5.52% 7.44% 4.68% Miscellaneous Exp. - 0.70 0.42 0.11 0.01 % Of Sales - 1.57% 1.33% 0.51% 0.10% EBITDA - 8.87 6.26 2.71 1.25 EBITDA Margin - 19.87% 19.75% 12.45% 12.99% Other Income - 2.20 1.15 0.60 0.16 Interest - 0.51 0.48 0.13 0.41 Depreciation - 0.77 0.36 0.20 0.14 PBT - 9.80 6.57 2.98 0.85 Tax - 2.76 0.56 -0.96 0.22 Tax Rate - 28.16% 8.52% -32.21% 25.88% PAT - 7.04 6.01 3.95 0.63 PAT before Minority Interest - 7.04 6.01 3.95 0.63 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 15.77% 18.96% 18.14% 6.55% PAT Growth - 17.14% 52.15% 526.98% EPS - 6.12 5.23 3.43 0.55

Description TTM Mar 24 Mar 23 Mar 22
Net Sales - 44.63 31.69 21.77 Net Sales Growth - 40.83% 45.57% Cost Of Goods Sold - 24.82 16.41 10.77 Gross Profit - 19.81 15.29 11.00 GP Margin - 44.39% 48.25% 50.53% Total Expenditure - 36.39 25.43 19.06 Power & Fuel Cost - 0.26 0.10 0.02 % Of Sales - 0.58% 0.32% 0.09% Employee Cost - 1.92 1.39 1.10 % Of Sales - 4.30% 4.39% 5.05% Manufacturing Exp. - 6.26 4.64 4.63 % Of Sales - 14.03% 14.64% 21.27% General & Admin Exp. - 0.91 0.71 0.81 % Of Sales - 2.04% 2.24% 3.72% Selling & Distn. Exp. - 1.44 1.75 1.62 % Of Sales - 3.23% 5.52% 7.44% Miscellaneous Exp. - 0.78 0.42 0.11 % Of Sales - 1.75% 1.33% 0.51% EBITDA - 8.24 6.26 2.71 EBITDA Margin - 18.46% 19.75% 12.45% Other Income - 2.08 1.16 0.60 Interest - 0.65 0.48 0.13 Depreciation - 0.97 0.36 0.20 PBT - 8.70 6.58 2.98 Tax - 2.76 0.56 -0.96 Tax Rate - 31.72% 8.51% -32.21% PAT - 6.34 6.02 3.95 PAT before Minority Interest - 5.94 6.02 3.95 Minority Interest - 0.40 0.00 0.00 PAT Margin - 14.21% 19.00% 18.14% PAT Growth - 5.32% 52.41% EPS - 5.51 5.23 3.43

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 52.67 45.63 4.78 -0.47 Share Capital 11.50 11.50 8.00 5.00 Total Reserves 41.18 34.13 -3.22 -5.47 Non-Current Liabilities 3.51 0.01 0.45 2.73 Secured Loans 3.58 0.18 0.00 0.00 Unsecured Loans 0.00 0.27 1.42 4.53 Long Term Provisions 0.07 0.07 0.07 0.05 Current Liabilities 17.59 10.67 7.61 7.34 Trade Payables 7.58 4.81 5.23 4.02 Other Current Liabilities 5.44 2.78 1.28 3.25 Short Term Borrowings 2.17 2.51 0.60 0.00 Short Term Provisions 2.41 0.57 0.51 0.07 Total Liabilities 73.77 56.31 12.84 9.60 Net Block 7.62 3.11 1.43 1.18 Gross Block 9.55 4.27 2.23 1.77 Accumulated Depreciation 1.93 1.16 0.80 0.59 Non Current Assets 20.09 8.09 2.15 1.86 Capital Work in Progress 4.03 0.23 0.00 0.00 Non Current Investment 4.40 4.04 0.05 0.00 Long Term Loans & Adv. 4.04 0.71 0.67 0.68 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 53.66 48.18 10.69 7.74 Current Investments 0.00 0.00 0.00 0.00 Inventories 11.06 7.17 3.71 5.27 Sundry Debtors 13.76 12.15 4.97 0.64 Cash & Bank 6.01 13.77 0.13 0.09 Other Current Assets 22.84 2.72 0.09 0.01 Short Term Loans & Adv. 20.71 12.38 1.79 1.73 Net Current Assets 36.07 37.52 3.08 0.40 Total Assets 73.77 56.30 12.84 9.60

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 52.90 45.63 4.78 Share Capital 11.50 11.50 8.00 Total Reserves 40.41 34.14 -3.22 Non-Current Liabilities 12.72 3.41 0.45 Secured Loans 8.81 2.75 0.00 Unsecured Loans 3.99 1.11 1.42 Long Term Provisions 0.07 0.07 0.07 Current Liabilities 20.94 11.86 7.62 Trade Payables 7.54 4.81 5.23 Other Current Liabilities 7.17 3.97 1.29 Short Term Borrowings 3.81 2.51 0.60 Short Term Provisions 2.43 0.57 0.51 Total Liabilities 87.61 62.37 12.85 Net Block 20.90 3.16 1.43 Gross Block 23.03 4.32 2.23 Accumulated Depreciation 2.14 1.16 0.80 Non Current Assets 32.99 12.18 2.10 Capital Work in Progress 4.03 4.83 0.00 Non Current Investment 3.77 3.34 0.00 Long Term Loans & Adv. 4.29 0.85 0.67 Other Non Current Assets 0.00 0.00 0.00 Current Assets 52.66 49.54 10.72 Current Investments 0.00 0.00 0.00 Inventories 12.58 7.17 3.71 Sundry Debtors 13.44 12.09 4.97 Cash & Bank 6.65 13.78 0.16 Other Current Assets 19.98 2.72 0.09 Short Term Loans & Adv. 17.84 13.78 1.79 Net Current Assets 31.72 37.68 3.10 Total Assets 87.62 62.39 12.85

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 0.90 -16.60 -0.19 1.48 PBT 9.80 6.57 2.98 0.85 Adjustment -0.53 0.08 0.33 0.55 Changes in Working Capital -5.99 -22.72 -3.65 0.08 Cash after chg. in Working capital 3.28 -16.06 -0.33 1.48 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -2.38 -0.54 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.14 0.00 Cash From Investing Activity -11.01 -5.56 -0.50 -0.56 Net Fixed Assets -9.08 -2.27 -0.46 Net Investments -0.36 -3.99 -0.05 Others -1.57 0.70 0.01 Cash from Financing Activity 2.35 35.80 0.80 -0.96 Net Cash Inflow / Outflow -7.76 13.64 0.11 -0.03 Opening Cash & Equivalents 13.77 0.13 0.01 0.12 Closing Cash & Equivalent 6.01 13.77 0.13 0.09

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 2.23 -19.00 -0.21 PBT 8.70 6.58 2.98 Adjustment 0.12 0.08 0.33 Changes in Working Capital -4.20 -25.12 -3.67 Cash after chg. in Working capital 4.61 -18.46 -0.36 Interest Paid 0.00 0.00 0.00 Tax Paid -2.38 -0.54 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.14 Cash From Investing Activity -20.36 -9.69 -0.45 Net Fixed Assets -9.08 -2.27 Net Investments -0.36 -3.99 Others -10.92 -3.43 Cash from Financing Activity 11.01 42.28 0.80 Net Cash Inflow / Outflow -7.13 13.60 0.14 Opening Cash & Equivalents 13.78 0.18 0.01 Closing Cash & Equivalent 6.65 13.78 0.16

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 45.79 39.65 5.97 -0.94 ROA 10.83% 17.39% 35.19% 9.08% ROE 14.34% 23.87% 183.40% 0.00% ROCE 19.11% 25.10% 55.11% 33.70% Fixed Asset Turnover 6.46 9.75 10.87 6.43 Receivable days 105.87 98.55 46.97 36.96 Inventory Days 74.50 62.65 75.32 117.74 Payable days 90.02 111.70 156.73 193.81 Cash Conversion Cycle 90.35 49.51 -34.45 -39.11 Total Debt/Equity 0.12 0.07 0.51 -9.61 Interest Cover 20.36 14.66 24.72 3.07

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 43.43 39.11 5.93 ROA 7.92% 16.00% 30.72% ROE 12.52% 24.21% 83.23% ROCE 15.32% 23.60% 43.21% Fixed Asset Turnover 3.26 9.68 9.76 Receivable days 104.41 98.21 83.27 Inventory Days 80.77 62.65 62.24 Payable days 90.79 111.70 177.25 Cash Conversion Cycle 94.40 49.17 -31.74 Total Debt/Equity 0.37 0.17 0.52 Interest Cover 14.42 14.67 24.72

Top Investors:

nav capital vcc - nav capital emerging star fund

goenka business and finance limited

chetan muktilal mehta huf

axita industries private limited

Annual Reports:

News Update:

Trident Lifeline completes acquisition of 50.49% stake in TLL Parenterals
3rd Dec 2024, 11:57 AM

With this, TLL Parenterals has become subsidiary of the Company
Read More
Trident Lifeline - Quarterly Results
19th Oct 2024, 18:01 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback